Using RNA Standards to Compare PCR Platforms
Author Information
Author(s): Devonshire Alison S, Elaswarapu Ramnath, Foy Carole A
Primary Institution: LGC Limited
Hypothesis
Can universal RNA standards improve the comparability of RT-qPCR assays across different platforms?
Conclusion
Universal RNA standards can help evaluate the performance of different RT-qPCR platforms, showing that the BioMark system performs comparably to the ABI 7900HT system when using pre-amplified cDNA.
Supporting Evidence
- The study demonstrated that pre-amplification of cDNA samples improved the accuracy and precision of measurements.
- Results indicated that the linear detection range of the BioMark arrays was similar to that of the ABI 7900HT system when pre-amplified cDNA was used.
- High rates of PCR failures were observed at low RNA copy numbers, highlighting the importance of pre-amplification.
Takeaway
This study shows that using special RNA samples can help scientists compare different ways of measuring genes, making sure they get accurate results no matter what machine they use.
Methodology
The study compared the performance of the Fluidigm BioMark dynamic arrays with the ABI 7900HT system using RNA standards and assessed the impact of pre-amplification on detection accuracy.
Potential Biases
Potential bias due to the use of specific RNA standards that may not represent all biological samples.
Limitations
The study primarily focused on comparing two platforms and may not generalize to all RT-qPCR systems.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website